OSL oncosil medical ltd

2.43%

$1.01

Then why did the FDA designate the Oncosil device as...

First 47 Last

Share
Profile

Follow
Gekkowolf

2,588 Posts.

257

24/03/21

12:36

Post #: 52001704
Share

Originally posted by DrDopamine: ↑

JohnCohen: to answer your question directly the device has a very long way to go before it’s standard of care. To get there they’ll need much more data, almost certainly a good randomised control trial (RCT).
where does this sit: at the moment the device has not shown it’s better than anything in pc. It’s not shown itself to be better or safer than modern radiotherapy in pancreatic cancer (I stress: modern). One can’t definitely say it adds any benefit to modern chemotherapy although there were some promising signals in panco.
but the limitation of panco trial is that it’s small, which means higher risk you get over-estimated results like resection rates that fail to play out when you do a bigger more controlled trial. . oncologists will note this and decide. No national funding agency will pay for this based on current data.
uptake? Well you can see for yourself. I expect limited uptake, private pay mainly. Also look at Singapore, device approved many months ago, high tech health system and unlike Europe they’re less affected by COVID . Any usage there?
i said before I see this device in same bucket as a number of other devices that have been tried in this cancer. None of them have become standard of care. I’ve not changed my position.
Fully agree with a comment I saw before on this forum: this device looks to be 10 years too late.

Expand

Then why did the FDA designate the Oncosil device as breakthrough technology in 2020 if it is 10 years too late?

OSL Price at posting: 9.3¢ Sentiment: Hold Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

PIQ

Proteomics notches up as company launches PromarkerD into the US

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

First 47 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.01		Change -0.025(2.43%)		Mkt cap ! $14.29M

Open	High	Low	Value	Volume
$1.04	$1.05	$1.00	$41.05K	40.86K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$1.01

Sellers (Offers)

Price($)	Vol.	No.
$1.05	1249	1

View Market Depth

No.	Vol.	Price($)
1	17640	1.000
1	1000	0.990
1	2875	0.980
2	6000	0.970
1	1000	0.960

Price($)	Vol.	No.
1.045	1249	1
1.050	25048	2
1.075	1879	1
1.090	375	1
1.180	2500	1

Last trade - 15.47pm 20/06/2025 (20 minute delay)

OSL (ASX) Chart

Then why did the FDA designate the Oncosil device as...

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Proteomics notches up as company launches PromarkerD into the US

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Then why did the FDA designate the Oncosil device as...

Top Stories

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Novo flags antimony and gold in the Pilbara – but does it need to step back?

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Proteomics notches up as company launches PromarkerD into the US

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News